Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
75
AKRO
Akero Therapeutics
Last Price:
27.48
Seasonality Move:
37.18%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.6 | Buy |
20-day SMA: | 26.6 | Buy |
50-day SMA: | 26.23 | Buy |
200-day SMA: | 23.45 | Buy |
8-day EMA: | 26.89 | Buy |
20-day EMA: | 26.5 | Buy |
50-day EMA: | 25.74 | Buy |
200-day EMA: | 25.56 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 61.72 | Buy |
Chaikin Money Flow: | 21177 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.62 - 27.2) | Buy |
Bollinger Bands (100): | (20.94 - 26.66) | Buy |
Akero Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 28.00 while AKRO 8-day simple moving average is 26.60, which is a Buy signal.
- The stock price of AKRO is 28.00 while Akero Therapeutics 20-day SMA is 26.60, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 26.23 while AKRO share price is 28.00, making it a Buy technically.
- AKRO stock price is 28.00 and Akero Therapeutics 200-day simple moving average is 23.45, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $28.00. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
1.94B
Price in USD:
28.00
Share Volume:
468.91K
Akero Therapeutics 52-Week Range
52-Week High:
51.24
52-Week Low:
11.25
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 28.00 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 28.00 while AKRO 8-day exponential moving average is 26.89, which is a Buy signal.
- The stock price of AKRO is 28.00 while Akero Therapeutics 20-day EMA is 26.50, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 25.74 while AKRO share price is 28.00, making it a Buy technically.
- AKRO stock price is 28.00 and Akero Therapeutics 200-day simple moving average is 25.56, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 0.37, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 61.72, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (25.62 - 27.2), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (20.94 - 26.66), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.